Effects of fluoroquinolone antibiotics on the insulin release and the serum glucose concentration in rats

Japanese Pharmacology and Therapeutics

Volumn 35, Issue 10, 2007, Pages 1061-1068

  Akita, Megumi ^a   Yagi, Yukihiro ^a   Hiratsuka, Kazuyuki ^a   Kurosawa, Tohru ^a   Ogawa, Yoshiji ^b   Suda, Toshihiro ^b  

^a MEIJI SEIKA KAISHA LTD   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

Fluoroquinolone; Hypoglycemia; Insulin; Rat

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; GLIBENCLAMIDE; GLUCOSE; INSULIN; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; UNCLASSIFIED DRUG; URIFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; NONHUMAN; RAT;

EID: 36849083980     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ball P. Adverse drug reactions : implications for the development of fluoroquinolones. J Antimicrob Chemother 2003 ; 51 : 21-7.
2. Paton JH, Reeves DS. Clinical features and management of adverse effects of quinolone antibacteriais. Drug Saf 1991 ; 6 : 8-27.
3. Baker SE, Hangii MC. Possible gatifloxacin-induced hypoglycemia. Ann Pharmacother 2002 ; 36 : 1722-6.
4. Gajjar DA, LaCreta FP, Kollia GD, Stolz RR, Berger S, Smith WB, et. al. Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise. Pharmacotherapy 2000 ; 20 : 76S-86S.
5. LeBlanc M, Belanger C, Cossette P. Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy. Pharmacotherapy 2004 ; 24 : 926-31.
6. Rubinstein E. History of quinolones and their side effects. Chemotherapy 2001 ; 47 : 3-8.
7. Japanese source
8. Maeda N, Tamagawa T, Niki I, Miura H, Ozawa K, Watanabe G, et. al. Increase in insulin release from rat pancreatic islets by quinolone antibiotics. Br J Pharmacol 1996 ; 117 : 372-6.
9. + channels. Life Sci 2003 ; 73 : 429-35.
10. + channels. Eur J Pharmacol 2004 ; 497 : 111-7.
11. Menzies DJ, Dorsainvil PA, Cunha BA, Johnson DH. Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents. Am J Med 2002 ; 113 : 232-4.
12. Biggs WS. Hyoiglycemia and hyperglycemia associated with gatifloxacin use in elderly patients. J Am Board Fam Pract 2003 ; 16 : 455-7.
13. Ostenson CG, Nylen A, Grill V, Gutniak M, Efendic S. Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas : evidence for a direct, non-paracrine effect. Diabetologia 1986 ; 29 : 861-7.
14. Proks P, Reimann F, Green N, Gribble F, Ashcroft F, Sulfonylurea stimulation of insulin secretion. Diabetes 2002 ; 51 : S368-76.
15. Roberge RJ, Kaplan R, Frank R, Fore C. Glyburide-ciprofloxacin interaction with resistant hypoglycemia. Annnals of Emergency Medicine 2000 ; 36 : 160-3.